Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Avantium Technologies

9 Disclosed Funding Rounds $199,790,571

0 Participating Investments


Pharmaceutical, Chemical, Biotechnology, Renewable Energy

Avantium Technologies provides high-throughput R&D technologies for applications in the energy, chemicals and pharmaceutical industries.

Amsterdam, Noord-Holland, The Netherlands, Europe (NL)

Organizations in Amsterdam in Pharmaceutical,
Organizations in Amsterdam in Chemical,
Organizations in Amsterdam in Biotechnology,
Organizations in Amsterdam in Renewable Energy,
Organizations in Noord-Holland in Pharmaceutical,
Organizations in Noord-Holland in Chemical,
Organizations in Noord-Holland in Biotechnology,
Organizations in Noord-Holland in Renewable Energy,
Organizations in The Netherlands in Pharmaceutical,
Organizations in The Netherlands in Chemical,
Organizations in The Netherlands in Biotechnology,
Organizations in The Netherlands in Renewable Energy,
Organizations in Europe in Pharmaceutical,
Organizations in Europe in Chemical,
Organizations in Europe in Biotechnology,
Organizations in Europe in Renewable Energy

Investors in Amsterdam in Pharmaceutical,
Investors in Amsterdam in Chemical,
Investors in Amsterdam in Biotechnology,
Investors in Amsterdam in Renewable Energy,
Investors in Noord-Holland in Pharmaceutical,
Investors in Noord-Holland in Chemical,
Investors in Noord-Holland in Biotechnology,
Investors in Noord-Holland in Renewable Energy,
Investors in The Netherlands in Pharmaceutical,
Investors in The Netherlands in Chemical,
Investors in The Netherlands in Biotechnology,
Investors in The Netherlands in Renewable Energy,
Investors in Europe in Pharmaceutical,
Investors in Europe in Chemical,
Investors in Europe in Biotechnology,
Investors in Europe in Renewable Energy

European Union (EU) (0 Investors) (0 Startups)

Founded date 01, 2000

Operating Status Active

Funding Stage IPO

Last Funding Type Grant

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands. Avantium's proprietary high-throughput technology enables a faster and more cost-effective development of new and improved products and production processes. Using its unique rational approach towards the design of experiments and data analysis, Avantium is capable of accomplishing innovations with superior success rate. Avantium has demonstrated the validity and commercial viability of its technology by successfully providing research services and tools to more than 70 companies worldwide, including many industry leaders. The company's mission is to increase the success rate and economics of product and process development. Building on its expertise and track record in the energy, chemicals and pharmaceutical industries, Avantium focuses on developing products in two fields: new biofuels and bio-based chemicals, and new crystal forms of marketed drugs under patent. Avantium's strategy is to progress its development programs and exploit the commercial value of its expanding patent portfolio by securing value-adding partnerships during the coming years. Avantium seeks continuous expansion of its profitable services and tools business. Avantium has assembled a team of highly educated professionals who are experts in catalysis, crystallography, organic chemistry, engineering of robotic systems, process engineering, statistics, cheminformatics and software development. Its teams collaborate closely with partner R&D organizations.

Date Round Raised Lead
August, 29, 2019 Grant $6,635,567 Horizon 2020
June, 27, 2019 Grant $1,478,295 -------
July, 01, 2018 Grant $6,249,854 -------
April, 19, 2016 Venture - Series Unknown $22,714,083 PMV
May, 22, 2014 Series G $52,490,993 -------
June, 09, 2011 Venture - Series Unknown $63,821,775 -------
October, 29, 2008 Venture - Series Unknown $18,000,000 Aescap Venture
January, 01, 2007 Venture - Series Unknown Undisclosed Thuja Capital
February, 18, 2002 Venture - Series Unknown $28,400,000 MVM Life Science Partners

Avantium Technologies Investors (29)

Investor Lead? Round Participating Raise Date Partners
Horizon 2020 Yes Grant $6,635,567 August, 29, 2019 -------
Horizon 2020 No Grant $1,478,295 June, 27, 2019 -------
EASME - EU Executive Agency for SMEs No Grant $6,249,854 July, 01, 2018 -------
Aster No Venture - Series Unknown $22,714,083 April, 19, 2016 -------
FPIM No Venture - Series Unknown $22,714,083 April, 19, 2016 -------
PMV Yes Venture - Series Unknown $22,714,083 April, 19, 2016 -------
Navitas Capital No Series G $52,490,993 May, 22, 2014 -------
Aster No Series G $52,490,993 May, 22, 2014 -------
ALPLA No Series G $52,490,993 May, 22, 2014 -------
De Hoge Dennen Capital No Series G $52,490,993 May, 22, 2014 -------
The Coca-Cola Company No Series G $52,490,993 May, 22, 2014 -------
Capricorn Partners No Series G $52,490,993 May, 22, 2014 -------
Aescap Venture No Series G $52,490,993 May, 22, 2014 -------
Sofinnova Partners No Series G $52,490,993 May, 22, 2014 -------
ING Corporate Investments No Series G $52,490,993 May, 22, 2014 -------
Danone No Series G $52,490,993 May, 22, 2014 -------
Aster No Venture - Series Unknown $63,821,775 June, 09, 2011 -------
De Hoge Dennen Capital No Venture - Series Unknown $63,821,775 June, 09, 2011 -------
Aescap Venture No Venture - Series Unknown $63,821,775 June, 09, 2011 -------
Sofinnova Investments No Venture - Series Unknown $63,821,775 June, 09, 2011 -------
Navitas Capital No Venture - Series Unknown $63,821,775 June, 09, 2011 -------
Capricorn Partners No Venture - Series Unknown $18,000,000 October, 29, 2008 -------
Aescap Venture Yes Venture - Series Unknown $18,000,000 October, 29, 2008 -------
ING Group No Venture - Series Unknown $18,000,000 October, 29, 2008 -------
Thuja Capital Yes Venture - Series Unknown Undisclosed January, 01, 2007 -------
Cazenove Capital No Venture - Series Unknown $28,400,000 February, 18, 2002 -------
SR One No Venture - Series Unknown $28,400,000 February, 18, 2002 -------
Pfizer Venture Investments No Venture - Series Unknown $28,400,000 February, 18, 2002 -------
MVM Life Science Partners Yes Venture - Series Unknown $28,400,000 February, 18, 2002 -------